MICHAEL ROBERTSON to Male
This is a "connection" page, showing publications MICHAEL ROBERTSON has written about Male.
Connection Strength
0.174
-
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma. Blood. 2026 Apr 30; 147(18):2041-2052.
Score: 0.039
-
Self-efficacy and Physical Activity in Overweight and Obese Adults Participating in a Worksite Weight Loss Intervention: Multistate Modeling of Wearable Device Data. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):769-776.
Score: 0.025
-
Urban-Rural Differences in Aerobic Physical Activity, Muscle Strengthening Exercise, and Screen-Time Sedentary Behavior. J Rural Health. 2018 09; 34(4):401-410.
Score: 0.022
-
A ?-opioid receptor superagonist analgesic with minimal adverse effects. Nature. 2026 Apr; 652(8112):1393-1404.
Score: 0.010
-
Smartphone-Based Physical Activity Program to Reduce "Chemo-Brain" Symptoms and Improve Health in Cancer Survivors With and Without Type 2 Diabetes: Protocol for a Single-Arm Pre-Post Pilot Trial. JMIR Res Protoc. 2025 Dec 10; 14:e79739.
Score: 0.010
-
Detecting Deception and Ensuring Data Integrity in a Nationwide mHealth Randomized Controlled Trial: Factorial Design Survey Study. J Med Internet Res. 2025 Jan 28; 27:e66384.
Score: 0.009
-
Hiding in plain sight: Cooperative Extension as an underutilized approach to improving cancer survivorship outcomes in underserved populations. J Cancer Surviv. 2026 Apr; 20(2):792-803.
Score: 0.009
-
The relation between individual-level factors and the implementation of classroom-based physical activity approaches among elementary school teachers. Transl Behav Med. 2021 04 07; 11(3):745-753.
Score: 0.007
-
Investigating the within-person relationships between activity levels and sleep duration using Fitbit data. Transl Behav Med. 2021 03 16; 11(2):619-624.
Score: 0.007
-
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial. Lancet Haematol. 2020 Sep; 7(9):e660-e670.
Score: 0.007
-
Health Behavior Changes During COVID-19 Pandemic and Subsequent "Stay-at-Home" Orders. Int J Environ Res Public Health. 2020 08 28; 17(17).
Score: 0.007
-
Implications for patient-provider communication and health self-efficacy among cancer survivors with multiple chronic conditions: results from the Health Information National Trends Survey. J Cancer Surviv. 2019 Oct; 13(5):663-672.
Score: 0.006
-
Just-in-Time Feedback in Diet and Physical Activity Interventions: Systematic Review and Practical Design Framework. J Med Internet Res. 2018 03 22; 20(3):e106.
Score: 0.006
-
Physical activity and exercise self-regulation in cancer survivors: A qualitative study. Psychooncology. 2018 02; 27(2):563-568.
Score: 0.005
-
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma. J Clin Oncol. 2014 Jun 10; 32(17):1797-803.
Score: 0.004
-
Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease. Clin Cancer Res. 2004 Aug 15; 10(16):5432-8.
Score: 0.002